X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1218) 1218
Publication (170) 170
Book Chapter (9) 9
Magazine Article (9) 9
Conference Proceeding (7) 7
Book Review (6) 6
Patent (4) 4
Book / eBook (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (565) 565
cardiac & cardiovascular systems (441) 441
index medicus (432) 432
male (373) 373
heart failure (367) 367
female (347) 347
middle aged (304) 304
aged (280) 280
mortality (229) 229
hypertension (135) 135
heart failure - drug therapy (126) 126
adult (124) 124
prognosis (124) 124
risk factors (122) 122
outcomes (117) 117
peripheral vascular disease (117) 117
treatment outcome (115) 115
hospitalization (110) 110
double-blind method (106) 106
heart failure - physiopathology (100) 100
cardiovascular (99) 99
heart failure - mortality (96) 96
abridged index medicus (89) 89
risk (88) 88
life sciences (87) 87
clinical trials (82) 82
myocardial-infarction (77) 77
follow-up studies (75) 75
cardiac patients (74) 74
left-ventricular dysfunction (73) 73
heart failure - therapy (70) 70
human health and pathology (67) 67
cardiology (65) 65
survival (65) 65
prospective studies (64) 64
analysis (63) 63
association (63) 63
cardiology and cardiovascular system (63) 63
pharmacology & pharmacy (63) 63
spironolactone (63) 63
myocardial infarction (62) 62
aged, 80 and over (61) 61
animals (61) 61
acute myocardial-infarction (59) 59
eplerenone (59) 59
heart attacks (59) 59
heart failure - diagnosis (59) 59
hypertension - drug therapy (59) 59
time factors (59) 59
cardiovascular diseases (55) 55
heart-failure (55) 55
trial (55) 55
blood pressure (54) 54
medicine, general & internal (54) 54
mineralocorticoid receptor antagonists - therapeutic use (53) 53
morbidity (53) 53
cardiovascular disease (52) 52
drug therapy (51) 51
management (51) 51
care and treatment (50) 50
heart (50) 50
therapy (50) 50
aldosterone (49) 49
diabetes (49) 49
proportional hazards models (49) 49
angiotensin-converting enzyme inhibitors - therapeutic use (47) 47
biomarkers (47) 47
patients (47) 47
double-blind (46) 46
guidelines (46) 46
heart diseases (46) 46
heart failure - blood (46) 46
hypertension - physiopathology (46) 46
blood-pressure (45) 45
clinical medicine (45) 45
diagnosis (45) 45
antihypertensive agents - therapeutic use (44) 44
cohort studies (44) 44
klinisk medicin (44) 44
[ sdv.mhep.csc ] life sciences [q-bio]/human health and pathology/cardiology and cardiovascular system (43) 43
stroke volume (43) 43
blood pressure - drug effects (42) 42
disease (42) 42
dysfunction (42) 42
risk assessment (42) 42
spironolactone - therapeutic use (42) 42
medicin och hälsovetenskap (41) 41
chronic disease (40) 40
clinical trials as topic (40) 40
medical and health sciences (39) 39
medicine (39) 39
spironolactone - analogs & derivatives (39) 39
biomarkers - blood (38) 38
randomized controlled trials as topic (38) 38
task-force (38) 38
article (37) 37
chronic kidney-disease (36) 36
hospitalization - statistics & numerical data (35) 35
echocardiography (34) 34
heart attack (34) 34
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1049) 1049
French (188) 188
Polish (4) 4
German (2) 2
Portuguese (2) 2
Dutch (1) 1
Italian (1) 1
Korean (1) 1
Russian (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Wang, Haidong and Wang, Linhong and Naghavi, Mohsen and Allen, Christine and Barber, Ryan M and Bhutta, Zulfiqar A and Carter, Austin and Casey, Daniel C and Charlson, Fiona J and Chen, Alan Zian and Chen, Wanqing and Coates, Matthew M and Coggeshall, Megan and Dandona, Lalit and Dandona, Rakhi and Dicker, Daniel J and Erskine, Holly E and Ferrari, Alize J and Fitzmaurice, Christina and Foreman, Kyle and Forouzanfar, Mohammad H and Fraser, Maya S and Fullman, Nancy and Gething, Peter W and Goldberg, Ellen M and Graetz, Nicholas and Haagsma, Juanita A and Hay, Simon I and Huynh, Chantal and Huynh, Grace and Johnson, Catherine O and Kassebaum, Nicholas J and Kinfu, Yohannes and Kulikoff, Xie Rachel and Kutz, Michael and Kyu, Hmwe H and Larson, Heidi J and Leung, Janni and Liang, Xiaofeng and Lim, Stephen S and Lind, Margaret and Lozano, Rafael and Marquez, Neal and Mensah, George A and Mikesell, Joe and Mokdad, Ali H and Mooney, Meghan D and Nguyen, Quyen Le and Nguyen, Grant and Nsoesie, Elaine and Pigott, David M and Pinho, Christine and Roth, Gregory A and Salomon, Joshua A and Sandar, Logan and Silpakit, Naris and Sligar, Amber and Sorensen, Reed J D and Stanaway, Jeffrey and Steiner, Caitlyn and Teeple, Stephanie and Thomas, Bernadette A and Troeger, Christopher and VanderZanden, Amelia and Vollset, Stein Emil and Wanga, Valentine and Whiteford, Harvey A and Wolock, Timothy and Zoeckler, Leo and Abate, Kalkidan Hassen and Abbafati, Cristiana and Abbas, Kaja M and Abd-Allah, Foad and Abera, Semaw Ferede and Abreu, Daisy M X and Abu-Raddad, Laith J and Abyu, Gebre Yitayih and Achoki, Tom and Adelekan, Ademola Lukman and Ademi, Zanfina and Adou, Arsène Kouablan and Adsuar, José C and Afanvi, Kossivi Agbelenko and Afshin, Ashkan and Agardh, Emilie Elisabet and Agarwal, Arnav and Agrawal, Anurag and Kiadaliri, Aliasghar Ahmad and Ajala, Oluremi N and Akanda, Ali Shafqat and Akinyemi, Rufus Olusola and Akinyemiju, Tomi F and Akseer, Nadia and Lami, Faris Hasan Al and Alabed, Samer and Al-Aly, Ziyad and Alam, Noore K M and Alam, Khurshid and Alasfoor, Deena and Aldhahri, Saleh Fahed and ... and GBD 015 Mortality and Causes Death and GBD 2015 Mortality and Causes of Death Collaborators and Högskolan Dalarna and Akademin Utbildning, hälsa och samhälle and Medicinsk vetenskap
The Lancet, ISSN 0140-6736, 10/2016, Volume 388, Issue 10053, pp. 1459 - 1544
Journal Article
Lancet, The, ISSN 0140-6736, 2015, Volume 385, Issue 9982, pp. 2067 - 2076
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2013, Volume 369, Issue 14, pp. 1327 - 1335
Alogliptin, a new antihyperglycemic agent of the DPP-4 class, was shown to have no significant effect on cardiovascular risk over a median treatment period of... 
INHIBITOR ALOGLIPTIN | MEDICINE, GENERAL & INTERNAL | CARDIOVASCULAR SAFETY | MELLITUS | OUTCOMES | MYOCARDIAL-INFARCTION | Hypoglycemic Agents - therapeutic use | Double-Blind Method | Dipeptidyl-Peptidase IV Inhibitors - adverse effects | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Uracil - therapeutic use | Male | Myocardial Infarction - complications | Myocardial Infarction - drug therapy | Uracil - adverse effects | Angina, Unstable - drug therapy | Piperidines - therapeutic use | Angina, Unstable - complications | Piperidines - adverse effects | Cardiovascular Diseases - mortality | Female | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Diabetes Mellitus, Type 2 - complications | Uracil - analogs & derivatives | Type 2 diabetes | Care and treatment | Acute coronary syndrome | Patient outcomes | Risk factors | Myocardial infarction | Heart attacks | Cardiovascular disease | Angina | Drug development | Hemoglobin | Diabetes mellitus (non-insulin dependent) | Drug dosages | Cerebral infarction | Stroke | Peptidase | Statistical analysis | Diabetes mellitus | Pancreatitis | Committees | FDA approval | Hypoglycemia | Angina pectoris | Studies | Product development | Diabetes | Acute coronary syndromes | Cardiovascular diseases | Health risk assessment | Cancer
Journal Article